• Login
• Admin

Coclitu, Catalina, Constantinescu, Cris S. and Tanasescu, Radu (2016) The future of multiple sclerosis treatments. Expert Review of Neurotherapeutics, 16 (12). ISSN 1744-8360

Full text not available from this repository.

Abstract

Introduction. There are not many conditions in which the last few decades have brought such a major change in the landscape of treatments as is the case of multiple sclerosis (MS). A number of disease modifying treatments (DMTs) are presently available for the treatment of the inflammatory phase of this disabling disease; however, the need for treating neurodegeneration and halting the progression of disability is still unmet.

Areas covered: In this paper we review the available information on existing and emerging DMTs and we discuss their place within the context of different treatment strategies in MS.

Expert Commentary: The future of MS treatments should include the development of new treatment strategies tackling disease progression, together with a better understanding of the side-effects and the best sequential strategy of implementation of available and emerging drugs.

Item Type:	Article
RIS ID:	https://nottingham-repository.worktribe.com/output/822232
Keywords:	Multiple sclerosis, Immunomodulation, Monoclonal antibodies, Remyelination, Repurposing
Schools/Departments:	University of Nottingham, UK > Faculty of Medicine and Health Sciences > School of Medicine
Identification Number:	https://doi.org/10.1080/14737175.2016.1243056
Depositing User:	Eprints, Support
Date Deposited:	19 Oct 2016 09:43
Last Modified:	04 May 2020 18:16
URI:	https://eprints.nottingham.ac.uk/id/eprint/37718

Actions (Archive Staff Only)

Edit View